Tafenoquine…..GSK Launches Phase 3 Malaria Drug Trials « New Drug Approvals

Tafenoquine…..GSK Launches Phase 3 Malaria Drug Trials « New Drug Approvals:



'via Blog this'

Binimetinib in phase 3 for for the treatment of metastatic or unresectable cutaneous melanoma with NRAS mutations and in combination with LGX-818 in adult patients with BRAF V600 « New Drug Approvals

Binimetinib in phase 3 for for the treatment of metastatic or unresectable cutaneous melanoma with NRAS mutations and in combination with LGX-818 in adult patients with BRAF V600 « New Drug Approvals:



'via Blog this'

RG 7388 is a MDM2 inhibitor with superior potency and selectivity in phase 1 trials « New Drug Approvals

RG 7388 is a MDM2 inhibitor with superior potency and selectivity in phase 1 trials « New Drug Approvals:



'via Blog this'

For many older men, impotence is treatable without drugs | lyranara.me

For many older men, impotence is treatable without drugs | lyranara.me:



'via Blog this'

Cobimetinib in phase 3 for metastatic melanoma « New Drug Approvals

Cobimetinib in phase 3 for metastatic melanoma « New Drug Approvals:



'via Blog this'

FDA Approves Cyramza, ramucirumab (IMC-1121B) for Stomach Cancer « New Drug Approvals

FDA Approves Cyramza, ramucirumab (IMC-1121B) for Stomach Cancer « New Drug Approvals:



'via Blog this'

Novel Diacylglycerol Acyltransferase-1 (DGAT-1) Inhibitor..1-(4-(4-Amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclobutanecarbonitrile « New Drug Approvals

Novel Diacylglycerol Acyltransferase-1 (DGAT-1) Inhibitor..1-(4-(4-Amino-2-methoxy-5-oxo-7,8-dihydropyrido[4,3-d]pyrimidin-6(5H)-yl)phenyl)cyclobutanecarbonitrile « New Drug Approvals:



'via Blog this'